Save Comparison | ![]() Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | ![]() Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | ![]() CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 2005 | Founding Date 1998 | Founding Date 2000 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Baton Rouge, US HQ | Locations Bethesda, US HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 3 | Employees 1721% increase | Employees 2763% decrease | Employees 15815% increase |
Valuation ($) | Valuation ($) 320.2 k | Valuation ($) 1.2 b | Valuation ($) 101.2 m | Valuation ($) 307.4 m |
Twitter followers | Twitter followers 2.4 k | Twitter followers 2.3 k | Twitter followers 1.1 k | Twitter followers 889 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 616184 | Alexa Website Rank 411721 | Alexa Website Rank 281860 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3 | Employee Rating 3.4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.4m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $57.5m (FY, 2019) |
Net income | Net income ($9.4m) (FY, 2019) | Net income ($20.3m) (FY, 2019) | Net income ($17.3m) (FY, 2019) | Net income ($102.2m) (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 135.9m | Total funding raised $ 79.4m | Total funding raised $ 132.4m |
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View companyMerrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyCytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company